Slideshow
Author(s):
A new analysis provides a comprehensive update on this significant, and growing, cause of disability and death.
Eli Lilly Announces Expanded Services to Early Diagnosis and Access Alzheimer Disease Care
Advancing Parkinson’s Disease Care While Maintaining Focus on Dyskinesia
This Week on NeurologyLive® — March 31, 2025
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
NeurologyLive® Brain Games: March 30, 2025
Fremanezumab Reduces Acute Medication Use and Migraine Symptoms in Episodic Migraine, Phase 2b/3 Trial Shows